CLINICAL_TRIALS
trial_result
· 2019-08-16
Clinical Trial Update: A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) [Phase 2]
Summary
Phase 2 clinical trial investigating patients with smoldering and active multiple myeloma is currently enrolling by invitation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Landspitali University Hospital | Conditions: Multiple Myeloma, Smoldering Multiple Myeloma | Phase 2 | Status: ENROLLING_BY_INVITATION